Operating
Change in Income Taxes
Pfizer Change in Income Taxes remained flat by 0.0% to -$701.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 108.6%, from -$336.25M to -$701.25M. Over 4 years (FY 2021 to FY 2025), Change in Income Taxes shows a downward trend with a 24.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ3 2025
How to read this metric
An increase in tax liabilities acts as a source of cash, while a decrease indicates cash outflows for tax settlements.
Detailed definition
This metric tracks the net change in income tax liabilities or receivables resulting from timing differences between tax...
Peer comparison
Standard across all industries; highly dependent on global tax jurisdictions and specific corporate tax planning strategies.
Metric ID:
cf_change_in_income_taxesHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$1.17B | -$545.00M | -$982.00M | -$1.35B | -$2.81B |
| YoY Change | — | +53.3% | -80.2% | -37.0% | -108.6% |
Range-$2.81B – -$545.00M
CAGR+24.5%
Avg YoY Growth-43.1%
Median YoY Growth-58.6%
Current Streak3 years decline
Change in Income Taxes at Other Companies
Frequently Asked Questions
- What is Pfizer's change in income taxes?
- Pfizer (PFE) reported change in income taxes of -$701.25M in Q4 2025.
- How has Pfizer's change in income taxes changed year-over-year?
- Pfizer's change in income taxes decreased by 108.6% year-over-year, from -$336.25M to -$701.25M.
- What is the long-term trend for Pfizer's change in income taxes?
- Over 4 years (2021 to 2025), Pfizer's change in income taxes has grown at a 24.5% compound annual growth rate (CAGR), from -$1.17B to -$2.81B.
- What does change in income taxes mean?
- The net change in cash owed for taxes or tax refunds due to the company.